Patent directory · USPTO A61K / A61P
Patents matching “antibody”
426 pharma patents match "antibody" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 426 pharmaceutical patents matching "antibody" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 20260144884
ANTI-LRRC15 ANTIBODY DRUG CONJUGATES
granted -
US 20260116972
CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY
granted -
US 20260115307
ANTI-FUCOSYL-GM1 ANTIBODY DRUG CONJUGATES
granted -
AU 2024342196
NOVEL ECTEINASCIDIN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF
granted -
AU 2024276234
METHODS OF TREATMENT USING ANTI-C-MET ANTIBODY DRUG CONJUGATES
granted -
US 2025325692
METHODS OF TREATMENT USING ANTI-SEZ6 ANTIBODY DRUG CONJUGATES
granted -
US 12427201
Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates
granted -
US 12428487
Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject
granted -
US 12415843
Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12410249
Low dose antibody-based methods for treating hematologic malignancies
granted -
US 12384853
Anti-HER2/PD1 bispecific antibody
granted -
US 12371503
Methods of treatment using a leptin receptor agonist antibody
granted -
US 12370264
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
granted -
US 12357703
Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping
granted -
US 12344665
Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibody
granted -
US 12343394
CD38 modulating antibody agents
granted -
US 12337199
Stable antibody formulation
granted -
US 12331107
Methods of treating pneumonia or respiratory failure associated with COVID-19 by administering an anti-LIGHT antibody
granted -
US 12329825
Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject
granted -
TW 202523278
Antibody drug conjugate platforms
granted -
US 12325753
Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy
granted -
US 12319729
Anti-Staphylococcus aureus specific antibody and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12319744
Treatment and prevention of hemophilic arthropathy with an antibody against endothelial cell protein C receptor (EPCR)
granted